| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 167,802 | 167,262 | 178,876 | 201,188 | | Cost of Revenue | 112,175 | 108,997 | 116,032 | 130,194 | | | Gross Profit | 55,627 | 58,265 | 62,844 | 70,994 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,455 | 5,866 | 9,274 | 9,341 | | Non Recurring | (5,657) | (268) | (77) |
-
| | Others | 6,023 | 5,906 | 5,708 | 5,696 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 47,806 | 46,761 | 47,939 | 55,957 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,607) | 4,927 | (1,320) | 4,481 | | Earnings Before Interest And Taxes | 44,199 | 51,688 | 46,619 | 60,679 | | Interest Expense | 3,895 | 3,840 | 3,800 | 408 | | Income Before Tax | 40,304 | 47,848 | 42,819 | 60,271 | | Income Tax Expense | 9,189 | 17,884 | 13,580 | 19,227 | | Minority Interest | (127) | (204) |
-
| (59) | | | | Net Income From Continuing Ops | 30,988 | 29,760 | 29,239 | 41,044 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,988 | 29,760 | 29,239 | 41,044 | | Preferred Stock And Other Adjustments |
-
| 47 | (47) |
-
| | | Net Income Applicable To Common Shares | $30,988 | $29,807 | $29,192 | $41,044 |
|
1.35% Nasdaq 
Income Statement
